选择性眼睑牵肌切除术与原地肌切断术治疗Meige综合征难治性眼睑痉挛
本研究回顾性分析2013至2020年24例难治性Meige综合征患者,采用选择性眼睑牵肌切除术与原地肌切断术联合上睑下垂矫正及下睑紧缩术。术后肉毒素治疗量由术前49.2±12.8 U/2.7±0.8个月降至35.4±7.8 U/3.8±0.7个月,功能残疾评分由76.7±17.5%降至15.6±9.9%(P<0.001),患者满意度高(Likert 4.5±0.5)。
要点
- 24例难治性Meige综合征患者接受选择性眼睑牵肌切除术与原地肌切断术联合眼睑整形。
- 术后肉毒素治疗量由49.2±12.8 U/2.7±0.8个月降至35.4±7.8 U/3.8±0.7个月。
- 功能残疾评分由术前76.7±17.5%改善至术后15.6±9.9%(P<0.001)。
核心结论
- 选择性眼睑牵肌切除术与原地肌切断术联合眼睑整形矫正及下睑紧缩术,可为难治性Meige综合征患者带来持久的功能与美学效果,并发症轻微。
研究设计与样本
- 本研究为回顾性综述,纳入2013年至2020年间24例难治性Meige综合征患者。
- 手术包括选择性眼睑牵肌切除术与原地肌切断术,并针对上睑下垂行提上睑肌折叠术、针对下睑松弛行外侧睑板整形术或睑外翻矫正术。
- 记录并分析患者人口学特征、相关疾病、药物治疗史、相关手术操作、最终美学效果及功能残疾评分和肉毒素治疗变化。
主要发现
- 患者平均年龄65.2±8.9岁。
- 21例(87.5%)接受提上睑肌折叠术矫正上睑下垂,平均长度11.2±2.9 mm。
- 16例(66.7%)接受五边形睑板切除术行外侧睑板整形术,平均宽度3.9±0.8 mm。
- 5例(20.8%)接受外侧睑外翻矫正术。
- 在总共96个手术眼睑中,3个眼睑(3.1%)因术后轻度轮廓凹陷行瘢痕修整联合脂肪移植。
关键数值与推荐
- 肉毒素治疗平均剂量由术前49.2±12.8 U(每2.7±0.8个月一次)降至术后35.4±7.8 U(每3.8±0.7个月一次)。
- 功能残疾评分由术前76.7±17.5%改善至术后15.6±9.9%(P<0.001)。
- 所有患者对功能与美学效果满意度高(Likert量表4.5±0.5)。
临床怎么用
- 对于肉毒素治疗难治的Meige综合征患者,可考虑选择性眼睑牵肌切除术与原地肌切断术联合上睑下垂矫正及下睑紧缩术。
- 术后需监测有无轮廓凹陷等并发症,必要时行瘢痕修整联合脂肪移植。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meige syndrome is characterized by involuntary blepharospasm and varied subphenotypes of oromandibular tonic-clonic muscle contraction. Despite botulinum toxin (BTx) being the mainstay of treatment for Meige syndrome, a small subset of patients remain refractory to its effects because the disease is a form of functional blindness. An integrative surgical procedure combining selective myectomy and myotomy in situ of eyelid protractors, blepharoptosis correction, and tightening of the lower eyelid laxity was first applied to treat refractory blepharospasm in patients with Meige syndrome. MATERIALS AND METHODS: This study is a retrospective review conducted on 24 patients with refractory Meige syndrome between 2013 and 2020. Besides selective myectomy and myotomy in situ of eyelid protractors, levator plication and lateral tarsoplasty or canthopexy was performed for blepharoptosis correction and lower eyelid tightening, respectively. Patient demographics, associated diseases, medical treatment history, associated surgical procedures, final aesthetic outcomes, and therapeutic effects as reflected by changes in function disability score and Botox (BTx) treatment were thoroughly recorded and analyzed. RESULTS: The mean age of the patients was 65.2 ± 8.9 years. Twenty-one patients (87.5%) received blepharoptosis correction by levator plication with an average of 11.2 ± 2.9 mm in length. Lateral tarsoplasty was performed in 16 patients (66.7%) by pentagonal tarsal resection with an average of 3.9 ± 0.8 mm in width. Five patients (20.8%) received lateral canthopexy. Among the total of 96 operated eyelids, scar revision with fat graft was performed in 3 eyelids (3.1%). The average amount of BTx treatment decreased from 49.2 ± 12.8 U once every 2.7 ± 0.8 months before surgery to 35.4 ± 7.8 U once every 3.8 ± 0.7 months after surgery. Function disability score improved from 76.7 ± 17.5% preoperatively to 15.6 ± 9.9% postoperatively ( P < 0.001). Only 3 upper eyelids (3.1%) received scar revision and fat grafting due to minor postoperative contour depression. All patients expressed high satisfaction with both functional and aesthetic outcomes (Likert scale 4.5 ± 0.5). CONCLUSIONS: Selective myectomy and myotomy in situ of eyelid protractors combining blepharoplasty correction and lower eyelid tightening can produce long-lasting functional and aesthetic results with minimal complication in patients with refractory Meige syndrome.
引用
- Lai CS, Wang YC, Ramachandran S, et al. Selective Myectomy and Myotomy In Situ for the Management of Refractory Blepharospasm in Meige Syndrome. Ann Plast Surg. 2023. PMID: 36752539. doi:10.1097/SAP.0000000000003367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。